IL96592A - Piperidine compounds their preparation and pharmaceutical compositions containing them - Google Patents

Piperidine compounds their preparation and pharmaceutical compositions containing them

Info

Publication number
IL96592A
IL96592A IL9695290A IL9695290A IL96592A IL 96592 A IL96592 A IL 96592A IL 9695290 A IL9695290 A IL 9695290A IL 9695290 A IL9695290 A IL 9695290A IL 96592 A IL96592 A IL 96592A
Authority
IL
Israel
Prior art keywords
alkyl
piperidine
compound
trans
thienyl
Prior art date
Application number
IL9695290A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL96592A publication Critical patent/IL96592A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9695290A 1989-12-18 1990-12-07 Piperidine compounds their preparation and pharmaceutical compositions containing them IL96592A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK640289A DK640289D0 (da) 1989-12-18 1989-12-18 Ny heterocyklisk kemi

Publications (1)

Publication Number Publication Date
IL96592A true IL96592A (en) 1995-06-29

Family

ID=8148694

Family Applications (2)

Application Number Title Priority Date Filing Date
IL96592A IL96592A0 (en) 1989-12-18 1990-12-07 Piperidine compounds,their preparation and pharmaceutical compositions containing them
IL9695290A IL96592A (en) 1989-12-18 1990-12-07 Piperidine compounds their preparation and pharmaceutical compositions containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL96592A IL96592A0 (en) 1989-12-18 1990-12-07 Piperidine compounds,their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US5102894A (ja)
EP (1) EP0505465B1 (ja)
JP (1) JPH05502867A (ja)
CN (1) CN1052674A (ja)
AT (1) ATE135704T1 (ja)
AU (1) AU645722B2 (ja)
CA (1) CA2071480A1 (ja)
DE (1) DE69026110T2 (ja)
DK (2) DK640289D0 (ja)
ES (1) ES2084151T3 (ja)
FI (1) FI922826A (ja)
IE (1) IE904435A1 (ja)
IL (2) IL96592A0 (ja)
NO (2) NO922313L (ja)
PT (1) PT96235B (ja)
WO (1) WO1991009032A1 (ja)
ZA (1) ZA9010183B (ja)
ZW (1) ZW19190A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763589B1 (fr) * 1997-05-22 2001-01-05 Centre Nat Rech Scient Composes pour la preparation de medicaments destines au traitement de pathologies impliquant le glutamate extracellulaire, et leurs procedes d'obtention
AU9087301A (en) 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
US7531555B2 (en) 2003-10-01 2009-05-12 University Of Florida Research Foundation, Inc. Compositions and methods for selective inhibition of nicotine acetylcholine receptors
US8258305B2 (en) 2005-02-23 2012-09-04 Prexa Pharmaceuticals, Inc. Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications
AU2006216651A1 (en) * 2005-02-23 2006-08-31 Prexa Pharmaceuticals, Inc. Multimediator dopamine transport inhibitors, and uses related thereto

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895965A (en) * 1959-07-21 Process for the production of
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
DK231088D0 (da) * 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US5017585A (en) * 1986-11-03 1991-05-21 Novo Nordisk A/S Method of treating calcium overload
DK588289D0 (da) * 1989-11-22 1989-11-22 Ferrosan As Ny heterocyklisk kemi

Also Published As

Publication number Publication date
PT96235B (pt) 1998-06-30
PT96235A (pt) 1991-09-30
ZW19190A1 (en) 1991-06-05
ATE135704T1 (de) 1996-04-15
ES2084151T3 (es) 1996-05-01
IL96592A0 (en) 1991-09-16
FI922826A0 (fi) 1992-06-17
EP0505465B1 (en) 1996-03-20
DK640289D0 (da) 1989-12-18
AU6971691A (en) 1991-07-18
NO1994003I1 (no) 1994-07-01
CA2071480A1 (en) 1991-06-19
AU645722B2 (en) 1994-01-20
NO922313D0 (no) 1992-06-12
JPH05502867A (ja) 1993-05-20
DE69026110T2 (de) 1996-10-02
DE69026110D1 (de) 1996-04-25
IE904435A1 (en) 1991-06-19
DK0505465T3 (da) 1996-08-05
CN1052674A (zh) 1991-07-03
EP0505465A1 (en) 1992-09-30
NO922313L (no) 1992-06-12
WO1991009032A1 (en) 1991-06-27
ZA9010183B (en) 1991-10-30
US5102894A (en) 1992-04-07
FI922826A (fi) 1992-06-17

Similar Documents

Publication Publication Date Title
US4877799A (en) Method of treating calcium overload in brain cells of mammals
EP0399504B1 (en) Aryloxyphenylpropylamines their preparation and use
EP0339579B1 (en) Piperidine compositions and their preparation and use
FR2581993A1 (fr) Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
EP0318727B1 (en) Aryloxphenylpropylamines and their preparation and use
EP0558487B1 (en) Piperidine compounds, their preparation and use
EP0576766A1 (en) Propanolamine derivatives, their preparation and use
US5102894A (en) Substituted piperidine compounds and their use
EP1978959B1 (en) Piperidine and piperazine derivatives
EP0571685A1 (en) Aryloxyheteroarylpropylamines, their preparation and use
US5227379A (en) Piperidine compounds and their preparation and use
US5017585A (en) Method of treating calcium overload
US5208232A (en) Piperidine compounds and their preparation and use
EP0639568A1 (en) Piperidine compounds, their preparation and use in the treatment of neurodegenerative disorders
JPH03294271A (ja) ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees